欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2378/001
药品名称Bendamustin Actavis
活性成分
    • bendamustine hydrochloride 2.5 mg/ml
剂型Powder for concentrate for solution for infusion
上市许可持有人Actavis Group PTC ehf. Dalshraun 1 220 Hafnarfjördur Iceland
参考成员国 - 产品名称Denmark (DK)
Bendamustin Actavis
互认成员国 - 产品名称
    • Croatia (HR)
    • Hungary (HU)
      Bendamustin Teva
    • Ireland (IE)
    • Austria (AT)
      Bendamustin Actavis 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
    • Greece (GR)
      BENDAMUSTINE/ACTAVIS
    • Bulgaria (BG)
      Bendamustine Actavis
    • Sweden (SE)
许可日期2015/02/18
最近更新日期2024/04/26
药物ATC编码
    • L01AA09 bendamustine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase